Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
CGEM2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in CULLINAN THERAPEUTICS INC
Yes. Vanguard Portfolio Management holds 738,741 shares of CGEM (Cullinan Therapeutics), worth $13.5M, as of its Q2 2026 13F filing. It increased the position by 186,188 shares (+33.7%) from Q1 2026. Vanguard Portfolio Management has held CGEM in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$13.5M
Current Shares
738,741
Total Value Change
+$5.6M
Total Shares Change
+186,188
Quarter-by-Quarter History
Other major holders of CGEM: BlackRock, Inc., BAUPOST GROUP LLC/MA, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP